Why is this study being conducted?
The purpose of this study is to evaluate the safety and immune response of multiple investigational vaccine formulations for respiratory syncytial virus (RSV) and Avian influenza.
Who is eligible to participate in this study?
You may be eligible if you are:
- 18 to 49 years of age
- In good general health
- Able to attend all scheduled study visits
Applicants who express interest in participating in this study will be reviewed and contacted as other requirement criteria must also be met.
What happens during the study?
Trial duration will be up to 7 months and participants will have between 5 and 8 trial visits.
Trial site visits will occur at the Griffith University Clinical Trial Unit on the Gold Coast.
You will receive either 1 or 2 vaccines during the study.
You will have 2 safety phone calls.
Volunteer to participate
Participation in this study is completely voluntary, and participants can decide to withdraw at any time.
Eligible participants will be reimbursed for their time and travel associated with each study visit.
Contact Subaat Khan
To learn more about this clinical trial, please contact:
Subaat Khan, Clinical Trial Coordinator.
0481 277 676 clinicaltrialunit@griffith.edu.au
This study has been approved by Bellberry Limited #2026-01-140 and GU HREC #2026/0350.
Can't see a trial for you?
Join our volunteer database to be contacted about new clinical trials